Using cost-effectiveness analysis to define a breast cancer benefits package for the uninsured

Breast Cancer Research and Treatment

Volumn 74, Issue 2, 2002, Pages 143-153

  Malin, Jennifer L ^a,b   Keeler, Emmett ^b   Wang, Cynthia ^b   Brook, Robert ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RAND CORPORATION   (United States)

Author keywords

Access to care; Breast cancer; Cost effectiveness analysis; Health policy; Insurance; Rationing; Uninsured

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; BREAST RECONSTRUCTION; CALCULATION; CANCER RADIOTHERAPY; COST; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEALTH INSURANCE; HUMAN; LAW; MAJOR CLINICAL STUDY; MASTECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; BREAST TUMOR; COST BENEFIT ANALYSIS; ECONOMICS; GOVERNMENT; HEALTH CARE COST; INSURANCE; MIDDLE AGED; PATIENT; PLASTIC SURGERY; QUALITY ADJUSTED LIFE YEAR; SEGMENTAL MASTECTOMY; STATISTICS; UNITED STATES;

BREAST NEOPLASMS; CALIFORNIA; CHEMOTHERAPY, ADJUVANT; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HEALTH POLICY; HUMAN; INSURANCE BENEFITS; MASTECTOMY, SEGMENTAL; MEDICALLY UNINSURED; MIDDLE AGE; QUALITY-ADJUSTED LIFE YEARS; RADIOTHERAPY, ADJUVANT; RECONSTRUCTIVE SURGICAL PROCEDURES; STATE GOVERNMENT; SUPPORT, NON-U.S. GOV'T; HUMANS; MIDDLE AGED;

EID: 0035990759     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016140228720     Document Type: Article

References (44)

1. Health insurance coverage: 1997
2. Ability to obtain medical care for the uninsured: How much does it vary across communities?
3. Morbidity and mortality weekly report: Strategies for providing follow-up and treatment services in the National Breast and Cervical Cancer Early Detection Program - United States, 1997
4. Tamoxifen for early breast cancer: An overview of the randomised trials
5. Polychemotherapy for early breast cancer: An overview of the randomised trials
6. New DEALES: Other approximations of life expectancy
7. Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer
8. Effects of radiotherapy and surgery in early breast cancer: An overview of the randomized trials
9. The effect of radical and conserving surgery on the QoL of early breast cancer patients
10. Psychosocial outcome in a randomized surgical trial for treatment of primary breast cancer
11. Psychosocial outcomes of breast cancer therapies: Lumpectomy versus mastectomy
12. Mastectomy versus conservative surgery: Psychosocial effects of the patient's choice of treatment
13. Tamoxifen, and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer
14. Effectiveness of adjuvant chemotherapy in combination with tamoxifen for node-positive postmenopausal breast cancer patients
15. Breast tumor recurrence following lumpectomy with and without breast irradiation: An overview of recent NSABP findings
16. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy
17. Locoregional failure at 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group
18. Postmastectomy attitudes in women who wear external breast prostheses compared to those who have undergone breast reconstructions
19. Routine follow up of breast cancer in primary care: Randomized trial
20. Autologous latissimus breast reconstruction in association with the abdominal advancement flap: A new refinement in breast reconstruction
21. Breast reconstruction with myocutaneous flaps in previously irradiated patients
22. Two months of doxorubicin and cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: Results from the National Surgical Adjuvant Bowel and Breast Project B-15
23. American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines
24. Impact of follow-up testing on survival and health-related QoL in breast cancer patients: A multi-center randomized controlled trial
25. Intensive diagnostic follow-up after treatment of primary breast cancer: A randomized trial
26. Cost-effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer
27. 'The high cost of dying' revisited
28. Management and survival of female breast cancer: Results of a national survey by the American College of Surgeons
29. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes
30. The tradeoff between severity of illness and treatment effect in cost-value analysis of health care
31. Cost-effectiveness of breast cancer screening: Preliminary results of a systematic review of the literature
32. Should the elderly receive chemotherapy for node-negative breast cancer? A cost-effectiveness analysis for examining total and active life-expectancy outcomes
33. The efficacy and cost-effectiveness of adjuvant therapy of early breast cancer in premenopausal women
34. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases